Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
J. S. Rø, T. H. Kluge, S. Taksdal & S. Skrede. (1974) Haemostatic Parameters and Erythrocyte Sedimentation Rate in Dextran-Warfarin Treated Vascular Surgical Patients. Scandinavian Journal of Thoracic and Cardiovascular Surgery 8:3, pages 206-215.
Read now
Read now
J. Krôll. (1965) Studies on The Effect of low Molecular Weight Dextran Upon the Clotting Process in Vitro. Scandinavian Journal of Clinical and Laboratory Investigation 17:1, pages 51-56.
Read now
Read now
H. C. Godal & I. Helle. (1963) In Vitro Studies on Fibrinogenolysis Induced by Streptokinase. Scandinavian Journal of Clinical and Laboratory Investigation 15:3, pages 303-310.
Read now
Read now
H. C. Godal. (1962) A Study on the Beta Naphtol Reaction of Plasma (»Fibrinogen B«-test). Scandinavian Journal of Clinical and Laboratory Investigation 14:2, pages 203-206.
Read now
Read now
P. Ollendorff. (1962) The Nature of the Anticoagulant Effect of Heparin, Protamine, Polybrene and Toluidine Blue. Scandinavian Journal of Clinical and Laboratory Investigation 14:3, pages 267-276.
Read now
Read now
H. C. Godal. (1962) The Antiheparin Effect of Platelets. Scandinavian Journal of Clinical and Laboratory Investigation 14:3, pages 223-229.
Read now
Read now
H. C. Godal. (1961) The Assay of Heparin in Thrombin Systems. Scandinavian Journal of Clinical and Laboratory Investigation 13:1, pages 153-166.
Read now
Read now
H. C. Godal. (1961) Heparin Tolerance and the Plasma Proteins. Scandinavian Journal of Clinical and Laboratory Investigation 13:2, pages 314-325.
Read now
Read now
H. C. Godal. (1961) The Influence of Heparin on the Fibrin Clot. Scandinavian Journal of Clinical and Laboratory Investigation 13:2, pages 306-313.
Read now
Read now
Articles from other publishers (31)
Marc E. Stone & Michael W. Vespe. (2023) Heparin Rebound: An In-Depth Review. Journal of Cardiothoracic and Vascular Anesthesia 37:4, pages 601-612.
Crossref
Crossref
Patrick Hecht, Martin Besser & Florian Falter. (2020) Are We Able to Dose Protamine Accurately Yet? A Review of the Protamine Conundrum. The Journal of ExtraCorporeal Technology 52:1, pages 63-70.
Crossref
Crossref
Jiwon Kwak & Soo Suk Lee. (2019) Sensitivity and reproducibility improvements in a human plasma immunoassay with removal of clotting factors. Analytical Biochemistry 585, pages 113410.
Crossref
Crossref
C.E. Dempfle & D.L. Heene. (1987) Purification of human plasma fibrinogen by chromatography on protamine-agarose. Thrombosis Research 46:1, pages 19-27.
Crossref
Crossref
Steven L. Gonias, John J. Pasqua, Charles Greenberg & Salvatore V. Pizzo. (1985) Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3. Thrombosis Research 39:1, pages 97-116.
Crossref
Crossref
Marta S. Killner & Robert S. Lees. (1981) High molecular weight fibrinogen derivatives in hyperlipidemia. Thrombosis Research 22:3, pages 329-344.
Crossref
Crossref
T. Ohtomo, K. Yoshida & A. Hasegawa. (1980) Comparison of the reactions of the compact-colony forming active substance (CCFAS) to the clumping-factor reaction in a strain ofStaphylococcus aureus with animal plasma. Medical Microbiology and Immunology 168:4, pages 261-265.
Crossref
Crossref
D. A. Lane, M. F. Scully, D. P. Thomas, V. V. Kakkar, I. L. Woolf & Roger Williams. (2008) Acquired Dysfibrinogenaemia in Acute and Chronic Liver Disease. British Journal of Haematology 35:2, pages 301-308.
Crossref
Crossref
M. Kopeć, Z. Węgrzynowicz, M. Zajdel, J. Sawecka & I. Szumiel. (1974) Effects of histones and dextran on some properties of fibrin, particularly on its susceptibility to plasmin. Thrombosis Research 5:3, pages 359-374.
Crossref
Crossref
U. Abildgaard, O.R. Ødegård, P. Kierulf & D.S. Pepper. (1974) Influence of platelet factor 4 on inhibited thrombin substrate reactions. Thrombosis Research 5:2, pages 185-196.
Crossref
Crossref
Clarence Merskey. (2006) PATHOGENESIS AND TREATMENT OF ALTERED BLOOD COAGULABILITY IN PATIENTS WITH MALIGNANT TUMORS*. Annals of the New York Academy of Sciences 230:1, pages 289-293.
Crossref
Crossref
Marie-Claude Guillin & Doris Menache. (1973) Fetal fibrinogen and fibrinogen Paris I: Comparative fibrin monomers aggregation studies. Thrombosis Research 3:2, pages 117-135.
Crossref
Crossref
Bruce Lages & S. S. Stivala. (2004) Copper ion binding and heparin interactions of human fibrinogen. Biopolymers 12:5, pages 961-974.
Crossref
Crossref
Carl Ditlef Jacobsen & John C. Hoak. (1973) Fibrinogen Iowa City : An abnormal fibrinogen with no clinical symptoms. Thrombosis Research 2:3, pages 261-270.
Crossref
Crossref
K. MiehlkeH. Holzhüter, S. M. Pusztai-Markos, E. Wenzel, H.-G. Ochs, B. Angelkort & K.-H. Stürner. 1973. Neunundsiebzigster Kongress. Neunundsiebzigster Kongress
1325
1327
.
Madeleine Klings, Ann L. Adams & Leo Vroman. (1972) Effects of protamine sulfate, polybrene and heparin on the behavior of plasma, plasma proteins, platelets and factor XII activity at interfaces. Thrombosis Research 1:5, pages 507-525.
Crossref
Crossref
C. EIKA. (2009) On the Mechanism of Platelet Aggregation Induced by Heparin, Protamine and Polybrene. Scandinavian Journal of Haematology 9:1-6, pages 248-257.
Crossref
Crossref
C. Eika & H. C. Godal. (2009) Thrombocytopenia in Rabbits Induced by Heparin, Protamine, and Polybrene. Scandinavian Journal of Haematology 8:6, pages 481-486.
Crossref
Crossref
H. C. Godal & G. Gjengedal. (2009) Activation of Coagulation by Heparin‐Protamine Complexes as Demonstrated by Thrombotest. Scandinavian Journal of Haematology 8:3, pages 194-199.
Crossref
Crossref
Gwendolyn J. Stewart. (2009) 21. AN ELECTRON MICROSCOPE STUDY OF THE POLYMERIZATION OF FIBRINOGEN AND ITS DERIVATIVES. Scandinavian Journal of Haematology 8:S13, pages 165-178.
Crossref
Crossref
Z.S. Latallo, Z. Wegrzynowicz, A.Z. Budzyński & M. Kopeć. (2009) 19. EFFECT OF PROTAMINE SULPHATE ON THE SOLUBILITY OF FIBRINOGEN, ITS DERIVATIVES AND OTHER PLASMA PROTEINS. Scandinavian Journal of Haematology 8:S13, pages 151-162.
Crossref
Crossref
Stefan Niewiarowski, Gwendolyn J. Stewart & Victor J. Marder. (1970) Formation of highly ordered polymers from fibrinogen and fibrin degradation products. Biochimica et Biophysica Acta (BBA) - Protein Structure 221:2, pages 326-341.
Crossref
Crossref
H. C. Godal. (2009) An Inhibitor to Fibrin Stabilizing Factor (FSF, Factor XIII). Scandinavian Journal of Haematology 7:1, pages 43-48.
Crossref
Crossref
U. Abildgaard. (2009) Inhibition of the Thrombin‐Fibrinogen Reaction by Heparin and Purified Cofactor. Scandinavian Journal of Haematology 5:6, pages 440-453.
Crossref
Crossref
U. Abildgaard. (2009) Inhibition of the Thrombin‐Fibrinogen Reaction by Heparin in the Absence of Cofactor. Scandinavian Journal of Haematology 5:6, pages 432-439.
Crossref
Crossref
H. Gans, V. Subramanian, S. John, A. R. Castaneda & C. W. Lillehei. (2006)
THEORETICAL AND PRACTICAL (CLINICAL) CONSIDERATIONS CONCERNING PROTEOLYTIC ENZYMES AND THEIR INHIBITORS WITH PARTICULAR REFERENCE TO CHANGES IN THE PLASMINOGEN‐PLASMIN SYSTEM OBSERVED DURING ASSISTED CIRCULATION IN MAN
*
. Annals of the New York Academy of Sciences 146:2, pages 721-736.
Crossref
Crossref
Louis Rosenfeld. (1965) Clot opacity and the thrombin-plasma reaction. Archives of Biochemistry and Biophysics 111:3, pages 660-670.
Crossref
Crossref
Margaret M. Niall & J.A. Owen. (1962) Heparin as a source of error in the determination of plasma albumin on a basis of selective dye-binding. Clinica Chimica Acta 7:2, pages 155-158.
Crossref
Crossref
Rudolf Holemans & Dionysius Adamis. (1962) HYPOTENSIVE ACTION OF PROTAMINE AND HEXADIMETHRINE. The Lancet 279:7226, pages 434-435.
Crossref
Crossref
R.J. Wieme & M.J. Lauryssens. (1962) LACTATE DEHYDROGENASE MULTIPLICITY IN NORMAL AND DISEASED HUMAN MUSCLE. The Lancet 279:7226, pages 433-434.
Crossref
Crossref
H. C. GODAL. (2009) Quantitative and Qualitative Changes in Fibrinogen Following Major Surgical Operations. Acta Medica Scandinavica 171:6, pages 687-694.
Crossref
Crossref